Bit Capital Gmb H Viking Therapeutics, Inc. Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 124,443 shares of VKTX stock, worth $3.67 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
124,443
Previous 18,000
591.35%
Holding current value
$3.67 Million
Previous $1.14 Billion
339.42%
% of portfolio
0.4%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
470Shares Held
63.8MCall Options Held
5.76MPut Options Held
3.43M-
Vanguard Group Inc Valley Forge, PA10.2MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$178 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$138 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$63.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$55.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.26B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...